Abstract:Most studies of gut microbiota have focused on relationships between a specific disease and the presence/abundance of one or a few bacterial species/genera. Whether the spatial and temporal distribution of gut microbiota, as a whole, affects or correlates with health is unknown, largely due to the absence of tools for dynamically monitoring the overall gut microbiota landscape inside living subjects. Here, we describe a novel, noninvasive, live imaging method for gut microbiota using 2-deoxy-2-[18F]fluoro-d-sorbitol (18F-FDS), a compound that specifically labeled gut bacteria in mice and hamsters following oral administration. Positron emission tomography-computed tomography (PET-CT) scanning showed that the radiolabel signal was concentrated in the gut (especially the large intestine), was absent when mice gut microbiota was depleted by antibiotic treatment, and was restored after transplanting antibiotic-treated mice with a fecal or probiotic bacterial mixture. Thus, 18F-FDS images microbiota, not gut tissue. The tissue distribution of 18F-FDS was the highest in the gut (∼3-fold higher than average), in contrast to 2-deoxy-2-[18F]fluoro-d-glucose, which concentrated in brain and many other organs. 2-[18F]fluoro-aminobenzoic acid, another bacterium-specific radioactive tracer, was unsuited for gut microbiota imaging due to unexpected stomach retention following oral administration. When similar gut microbiota imaging was done with hamsters, the spatial resolution increased significantly over that with mice, suggesting that even higher spatial resolution can be achieved with humans or large animals. Thus, our work establishes a new tool for noninvasive, live imaging of gut microbiota; the new tool may enable exploration of relationships between gut microbiota landscape and diseases in clinical settings. IMPORTANCE Gut microbiota dysbiosis correlates with many diseases, but such correlations derive mostly from relationships between one or a few bacteria and a particular disease. Since microbiota resemble complex forest ecosystems more closely than individual patches of trees, the overall landscape (spatial and temporal distribution) of gut bacteria may also affect/reflect disease development. Such a possibility has not been explored due to a lack of tools for directly visualizing natural landscape patterns of gut microbiota. The present work identified 2-deoxy-2-[18F]fluoro-d-sorbitol as a gut microbiota-specific radioactive tracer and developed a novel PET-CT scan-based imaging method that enables noninvasive, real-time imaging of the overall gut bacterial landscape. The method showed increased spatial resolution when hamsters replaced mice, suggesting that even higher spatial resolution could be achieved with larger animals such as humans. This novel technology establishes the feasibility of investigating spatial-temporal distribution dynamics of gut microbiota with many human diseases.

Metabolic fluorine labeling and hotspot imaging of dynamic gut microbiota in mice

In Situ Live Imaging of Gut Microbiota

Metabolic Labeling of Peptidoglycan with NIR‐II Dye Enables in Vivo Imaging of Gut Microbiota

Quantification of Bacterial Metabolic Activities in the Gut by D‐amino Acid‐Based in Vivo Labeling

Selective Imaging of Gram-Negative and Gram-Positive Microbiotas in the Mouse Gut

Revealing the in Vivo Growth and Division Patterns of Mouse Gut Bacteria

Universal membrane-labeling combined with expression of Katushka far-red fluorescent protein enables non-invasive dynamic and longitudinal quantitative 3D dual-color fluorescent imaging of multiple bacterial strains in mouse intestine

Encoding with a Fluorescence-Activating and Absorption-Shifting Tag Generates Living Bacterial Probes for Mammalian Microbiota Imaging.

Visualization of metabolites and microbes at high spatial resolution using MALDI mass spectrometry imaging and in situ fluorescence labeling

High Throughput and Quantitative Measurement of Microbial Metabolome by Gas Chromatography/Mass Spectrometry Using Automated Alkyl Chloroformate Derivatization.

Fluorescence-Activating and Absorption-Shifting Nanoprobes for Anaerobic Tracking of Gut Microbiota Derived Vesicles.

Positive-Charge-Based Small Molecule Dyes for Gut Microbiota Fluorescent Imaging

Bio-orthogonal Metabolic Fluorine Labeling Enables Deep-Tissue Visualization of Tumor Cells in Vivo by 19F Magnetic Resonance Imaging.

Spatiotemporally Resolved Tools for Analyzing Gut Microbiota

Imaging the in vivo growth patterns of bacteria in human gut Microbiota

Visual and Quantitative Analysis of Dietary Fiber‐Microbiota Interactions via Metabolic Labeling In Vivo

Integrated Identification of Growth Pattern and Taxon of Bacterium in Gut Microbiota Via Confocal Fluorescence Imaging-Oriented Single-Cell Sequencing

Imaging of Gut Bacterial Macroscopic Changes in Simulated Microgravity-Exposed Rats via In Vivo Metabolic Labeling

Glycan Metabolic Fluorine Labeling for in Vivo Visualization of Tumor Cells and in Situ Assessment of Glycosylation Variations.

Three‐Dimensional Quantitative Imaging of Native Microbiota Distribution in the Gut

Isotope-Coded On-Tissue Derivatization for Quantitative Mass Spectrometry Imaging of Short-Chain Fatty Acids in Biological Tissues